Atlas Trials

125I Seed Brachytherapy Combined With Immunotherapy for Primary, Recurrent, or Metastatic Malignant Tumors

Clinical trial NCT07277777 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07277777
Sponsor
Li Min
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Malignant Tumors
Start date
2026-01-01
Primary completion
2027-01-01
Enrollment
90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.